Search results
Results from the WOW.Com Content Network
Alumni of King's College, Newcastle (2 C, 132 P) Pages in category "Alumni of Newcastle University" The following 200 pages are in this category, out of approximately 454 total.
Neil Bartlett - chemist, creation of the first noble gas compounds (BSc and PhD at King's College, University of Durham, later Newcastle University) [18] Philip Beahon - eCommerce entrepreneur; sportswear brand founder . Graduated with a Bachelor of Laws in 2014. [19] Sue Beardsmore - television presenter [20] Alan Beith - politician [21]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate; Pages for logged out editors learn more
Newcastle University (legally the University of Newcastle upon Tyne) is a public research university based in Newcastle upon Tyne, England. It has overseas campuses in Singapore and Malaysia. The university is a red brick university and a member of the Russell Group, [7] an association of research-intensive UK universities.
Alumni of Newcastle University (3 C, 454 P) V. Vice-chancellors of Newcastle University (7 P) Pages in category "People associated with Newcastle University"
She was then a post-doctoral researcher at the University of Nottingham from 1982 to 1983, before joining Newcastle University in 1984 as a lecturer. [5] She was promoted to senior lecturer in 1988, and rose to be pro-vice-chancellor (1998 to 2004). [5] [4] She was vice-chancellor of Coventry University from 2004 to 2013. [5]
She is Regius Professor of Ageing at Newcastle University, and director of the Newcastle University Institute for Ageing. [ 1 ] [ 2 ] Robinson earned an MBBS in 1985 from Newcastle University, MRCGP in 1989, DFFP in 1991, DCH in 1998 from the University of London , and Dip ME 1992 from the University of Dundee .
Nicola Curtin is an English academic. She is Professor of Experimental Cancer Therapeutics at Newcastle University. [1] She is best known for being part of the Newcastle University team that developed Rubraca, a PARP inhibitor used as an anti-cancer agent addressing BRCA mutation, and for donating her share of the royalties to charity.